Treatment of Corneal Abrasions With Topical Tetracaine
Launched by NEW YORK PRESBYTERIAN BROOKLYN METHODIST HOSPITAL · May 10, 2016
Trial Information
Current as of September 08, 2025
Unknown status
Keywords
ClinConnect Summary
Corneal abrasion (CA) is one of the most common eye injuries, accounting for 10% of eye-related emergency visits.1 A 1985 survey showed that around 3% of all visits to US general practitioners were for corneal abrasions. In addition, in 2008, approximately 27,450 work-related eye injuries and illnesses occurred that caused missed time from work.1Due to the large number of nerve endings even small corneal injuries can produce significant pain. The discomfort is typically most pronounced in the first 24-48 hours, and in many cases showed a loss in time at work and disruption of daily activiti...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients \> 18 years of age with a primary diagnosis of uncomplicated corneal abrasion presenting to NYMH emergency department
- Exclusion Criteria:
- • Patients\<18 years of age with complicated corneal abrasions or other eye injuries
- • Present more than 36 hours after their initial injury
- • Had previous eye surgery or cataracts
- • Wear contact lenses or if their injury was caused from contact lens wear
- • Had injured both eyes
- • Unable to give informed consent
- • Current infectious or chemical conjunctivitis
- • Have a grossly contaminated foreign body in their eye
- • Currently suffering from an ocular infection
- • Currently or previously had herpes keratitis
- • Allergies to tetracaine or similar medication classes
- • Had an injury requiring urgent ophthalmologic evaluation; including penetrating eye injuries, large or complicated corneal abrasions, or injuries causing a significant disruption of visio)
- • Unable to attend follow up in 48 hours
About New York Presbyterian Brooklyn Methodist Hospital
New York Presbyterian Brooklyn Methodist Hospital is a leading healthcare institution committed to advancing medical research and improving patient care through innovative clinical trials. As a part of the NewYork-Presbyterian Healthcare System, the hospital integrates high-quality clinical services with a focus on patient-centered research. It fosters a multidisciplinary approach, collaborating with experts across various specialties to explore cutting-edge therapies and treatments that enhance health outcomes. The institution is dedicated to ethical research practices, ensuring the safety and well-being of participants while contributing to the broader medical community's understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brooklyn, New York, United States
Patients applied
Trial Officials
Laura Melville, M.D.
Study Director
New York Presbyterian Brooklyn Methodist Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials